Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19121913rdf:typepubmed:Citationlld:pubmed
pubmed-article:19121913lifeskim:mentionsumls-concept:C0038627lld:lifeskim
pubmed-article:19121913lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:19121913lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:19121913lifeskim:mentionsumls-concept:C0201699lld:lifeskim
pubmed-article:19121913lifeskim:mentionsumls-concept:C1705957lld:lifeskim
pubmed-article:19121913lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:19121913pubmed:issue2lld:pubmed
pubmed-article:19121913pubmed:dateCreated2009-2-9lld:pubmed
pubmed-article:19121913pubmed:abstractTextA simple method based on capillary electrophoresis with a capacitively coupled contactless conductivity detector (CE-C(4)D) was developed for the determination of suxamethonium (SUX) in a pharmaceutical formulation. A hydro-organic mixture, consisting of 100mM Tris-acetate buffer at pH 4.2 and acetonitrile (90:10, v/v), was selected as background electrolyte (BGE). The applied voltage was 30kV, and the sample injection was performed in the hydrodynamic mode. All analyses were carried out in a fused silica capillary with an internal diameter of 50 microm and a total length of 64.5cm. Under these conditions, a complete separation between SUX, sodium ions and the main degradation products (choline) was achieved in less than 4min. The presence of acetonitrile in the BGE allowed a reduction of SUX adsorption on the capillary wall. The CE-C(4)D method was validated, and trueness values between 98.8% and 101.1% were obtained with repeatability and intermediate precision values of 0.7-1.3% and 1.2-1.6%, respectively. Therefore, this method was found appropriate for controlling pharmaceutical formulations containing suxamethonium and degradation products.lld:pubmed
pubmed-article:19121913pubmed:languageenglld:pubmed
pubmed-article:19121913pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:citationSubsetIMlld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19121913pubmed:statusMEDLINElld:pubmed
pubmed-article:19121913pubmed:monthFeblld:pubmed
pubmed-article:19121913pubmed:issn0731-7085lld:pubmed
pubmed-article:19121913pubmed:authorpubmed-author:VeutheyJean-L...lld:pubmed
pubmed-article:19121913pubmed:authorpubmed-author:RudazSergeSlld:pubmed
pubmed-article:19121913pubmed:authorpubmed-author:BonnabryPasca...lld:pubmed
pubmed-article:19121913pubmed:authorpubmed-author:Fleury-Souver...lld:pubmed
pubmed-article:19121913pubmed:authorpubmed-author:NussbaumerSus...lld:pubmed
pubmed-article:19121913pubmed:issnTypePrintlld:pubmed
pubmed-article:19121913pubmed:day20lld:pubmed
pubmed-article:19121913pubmed:volume49lld:pubmed
pubmed-article:19121913pubmed:ownerNLMlld:pubmed
pubmed-article:19121913pubmed:authorsCompleteYlld:pubmed
pubmed-article:19121913pubmed:pagination333-7lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:meshHeadingpubmed-meshheading:19121913...lld:pubmed
pubmed-article:19121913pubmed:year2009lld:pubmed
pubmed-article:19121913pubmed:articleTitleDetermination of suxamethonium in a pharmaceutical formulation by capillary electrophoresis with contactless conductivity detection (CE-C(4)D).lld:pubmed
pubmed-article:19121913pubmed:affiliationPharmacy, University Hospitals of Geneva , Geneva, Switzerland.lld:pubmed
pubmed-article:19121913pubmed:publicationTypeJournal Articlelld:pubmed